During the past decade, Jiangsu Province Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jiangsu Province Hospital" #1 collaborator was "Bayer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Jiangsu Province Hospital" are "Acute Coronary Syndrome" (1 trials), "Carotid Artery Diseases" (1 trials), "Coronary Heart Disease" (1 trials), "Impaired Glucose Tolerance" (1 trials) and "Intracranial Aneurysms" (1 trials). Many other conditions were trialed in "Jiangsu Province Hospital" in a lesser frequency.

Most popular intervention types in "Jiangsu Province Hospital" are "Drug" (2 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Acarbose" (1 trials), "Axium Detachable Coil(Medtronic)" (1 trials), "BB-1701" (1 trials), "Carotid ultrasound examination 1" (1 trials) and "Carotid ultrasound examination 2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jiangsu Province Hospital" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Jiangsu Province Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Jiangsu Province Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jiangsu Province Hospital, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".